【Good News】Haibu Pharmaceuti★¶₽​cal's Riluzole raw materiaβ÷l has obtained the FDA¶​↓δ registration number in the United¥σ♦ States.

Classification:

Company News

Release time:

2024-10-30

01. Basic Information of Raw Mat•♦erials

Chinese Name: Relugolix
English Name: Relugolix
CAS NO.: 737789-87-6
Molecular Formula: C29H27F2N7O5S
Molecular Weight: 62‍£©3.63
Structural Formula:

02.Product Introduction

Relugolix is an oral gonadotropin-‌€λreleasing hormone (Gn$₹RH) receptor antagonist that can bloc♥€↔k the binding of endogenous GnRH →≤to its receptors, reducing the release¥↑§¥ of luteinizing hormone (LH¶×") and follicle-stimulatin‌÷♦g hormone (FSH), thereby inhib♥$​©iting the secretion of ovarian estr©↕ ✘adiol and progesterone, which can∏ ÷π improve various symptoms caused by"' uterine fibroids. At the same☆¶☆ε time, the reduction in L£$H and FSH release can lower te§✔¶stosterone secretion, thusΩ♣ inhibiting the growth of pros×™≤tate cancer cells.

On January 8, 2019, Takeφλβ≥da's Relugolix tablets ÷‍<₹(40mg) were approved f&∞or marketing by Japan's PMDA under the ✘₹brand name Relumina for theβ'¶∑ treatment and symptom relief of uteri≥≤ne fibroids.

On December 18, 2020, Myovant Scienc ↕★es' Relugolix tablets (120mg↓ε$) were approved for marketin∏™♠™g by the US FDA under the brand n♥∏™ ame Orgovyx as the firקδst oral GnRH receptor antagonist↑✘ for adult patients with ad  ♥★vanced prostate cancer.

On May 26, 2021, the ←↔FDA approved a new dru♠®g from Myovant Science ± £s and Pfizer called Myfembree (♣∏‍←each tablet contains Rel↔β≈§ugolix 40mg, Estradiol 1.0mgγ₹, Norethindrone Acetate 0.5mg), indica •ΩΩted for heavy bleeding related to uteri®"↓ne fibroids and pain causeσ₩d by endometriosis.

Dosage Form/Specification: φ&​Tablets, 40mg/tablet, 120mg/tabl‌​€÷et

Patent Status: Compound↓☆£γ patent expires in J "anuary 2024

03. Contact Us

Our company has a rich variety of raw ÷ ♣materials with stable supply; inquiriφ€λδes are welcome.
[Mr. Wei]:[Phone Number]; [Mr. Wu]:[Phone Number]

 

[Beijing Haibu Pharmaceut★≥₹®ical Technology Co., Ltd.₩γ] (referred to as 'Haibu Pharmaceuticalπ§') was established in [2005] &§"and is a high-tech enterprise with×¥ 'chemical drug research an→∞₩d development' as its coγ→→αre capability. It has a research center§♥ in Beijing, a raw materia €σ l drug and formulation pilot verifica>•‌tion center, and a GMP indus>↕₹¶trial production base mainly engaged≤♣ε in technical development and transfer of↓&£↔ chemical drugs, MAH • research and licensi ≈σ→ng, raw material drug-®∏₹related declarations aΩα♠ s well as commercial supply ofδ→ pharmaceutical inte​£₽rmediates and innovative or improλ♠♦ved drug research declφ aration etc., having been aw¥ ₽<arded 'Top [20] Pharmaceutical R& ε;D Companies in China$±±∞' for several consec∑<‍utive years and recognized as 'Beijing ₩×Science and Technology Research Develo€↑₹♦pment Institution', 'National H≠≈igh-tech Enterprise', 'Beij♣¥ing Yizhuang Enterprise Innovat£'ion Center'.
Haibu Pharmaceutical has r✘©¥ich experience in R&D tα↓σ☆ransfer production registrati♠δ÷"on declaration etc., across vaπε≈rious dosage forms including chemic☆'¥'al raw materials, oraφ☆✘≥l solids, liquid prep"✔arations, sterile injections, topical p₽‌reparations etc. The R&D products ∑&cover multiple therapeutic areas ✔ such as anti-tumor, anti-deprπ‍σφession, anti-epilepsy, anti-anx¶‍iety cardiovascular →↕♥♦diseases digestive system respi✔↔ratory system.

Previous Page

【Announcement】Beijing Haibu Ph₹≠armaceutical Technology Co., L​☆÷td. Hazardous Waste P ±•™ollution Prevention and Control  ≈♦αInformation Announcement

Beijing Hope Pharmaceutical Co., Ltd.≤​

SEO

COOKIES

Our website uses cookies and simi♣γ£lar technologies to ​£>≤personalize the adve®εεrtising shown to you and↓•γ  to help you get the besα↓t experience on our webs♥✘ite. For more information,‍♣& see our Privacy &am♥♣p; Cookie Policy

COOKIES

Our website uses cookies and simi♠☆'↔lar technologies to peσ→φαrsonalize the advertising shΩ>own to you and to help you get theπ‌≠α best experience on our website. For mo↑©εαre information, see our P★♠♠♦rivacy & Cookie Policy

These cookies are necessary for ba£✔sic functions such as payment. Standa♠×​rd cookies cannot be turned off ♠ ♥ and do not store any of youε♦✘r information.

These cookies collect information, such₩γ®β as how many people are using our site×β→‍ or which pages are popular, to help us±₽∏ improve the customer e‍₹xperience. Turning these cooki÷$es off will mean we can'≈± ∞t collect information to i׶×mprove your experience.

These cookies enable the web∞≈site to provide enhanc→↔ed functionality and pers♦' onalization. They may be set by us ♣★÷✘or by third-party providers whose serv↑λ₩ices we have added to our •​pages. If you do not allow these co÷♥♣okies, some or all of these πγ✔₹services may not fun↑ ∏≈ction properly.

These cookies help us understand wh∑∞↕at you are interested in so thaγε±t we can show you rele★φvant advertising on other wγ✘<™ebsites. Turning these cookies off " <'will mean we are unable to show you aλ±ny personalized adverti♣ ±λsing.